On December 6, 2013, the Government of Canada introduced new patient safety legislation, named the Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law). The Law would protect Canadian families and children from unsafe medicine by enabling the Government to:
It should be noted that Natural Health Products have been specifically excluded from this legislation. This is a significant development because for the first time NHPs have been recognized in the Food and Drugs Act as being distinct from drugs. This development serves as further recognition of the low risk nature of NHPs compared to pharmaceutical drugs.
The official press release can be found at http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2013/2013-174-eng.php.
NHP Consultant and FDA Consultant dicentra provides sought-after regulatory and scientific guidance on product and marketing compliance, quality assurance, research and development, new ingredient assessments and overall regulatory strategies for health-related products sold in North American marketplaces. Contact us at firstname.lastname@example.org or at 1-866-647-3279.